Health Condition 1: E782- Mixed hyperlipidemia
Conditions
Interventions
None listed
Sponsors
Dr Madhav Mahesh Kale
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 30 to 60 years, of either sex 2.Patients Diagnosed With Dyslipidemia as per NCEP ATP III or Indian Guidelines presenting abnormal values of Total Cholesterol more than or equal to 200 mg per dL ,LDL more than or equal to 130 mg per dL, Triglycerides more than or equal to 150 mg per dL ,HDL less than or equal to 40 mg per dL (men), less than or equal to 50 mg per dL (women) 3. Willing to give informed written consent 4. Patients having least any 2 Ayurvedic Lakshanas of Medoroga like Kshudra Shwasa , Dougandhya, Swedadhikya, Gatra Sada ,etc 5.Not currently on any lipid lowering medication OR can undergo a 2 weeks washout period Diagnosed with dyslipidemia (as per NCEP ATP III criteria).
Exclusion criteria
Exclusion criteria: 1. Known case of Diabetes Mellitus, Hypertension, or Cardiovascular Disease or established CAD, MI, Stroke 2. History of chronic liver disease or renal impairment having LFT, KFT abnormal 3. Pregnant or lactating women 4. Patients on long-term corticosteroids, antipsychotics, or immunosuppressants 5. Known allergy to the components of Varunadi Kashayam 6. Patients with secondary causes of dyslipidemia like hypothyroidism, nephrotic syndrome, etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in lipid profile parameters including total cholesterol low density lipoprotein cholesterol and triglycerides from baseline to end of treatment.Timepoint: Baseline and Day 90. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in high density lipoprotein cholesterol from baseline to end of treatment. Improvement in clinical symptoms related to dyslipidemia & Medoroga such as heaviness fatigue excessive sweating foul body odor & breathlessness. Occurrence of adverse events during the study period.Timepoint: Baseline & Day 90 for laboratory parameters. Periodic assessment during follow up visits i.e baseline, Day 30 , Day 60 & Day 90 for clinical symptoms & adverse events. | — |
Countries
India
Contacts
Public ContactDr Madhav Mahesh Kale
Dr. G. D.Pol Foundation, YMT Ayurvedic Medical Collage.Kharghar. Navi Mumbai
Outcome results
None listed